Home

Bone Biologics Corp - Common Stock (BBLG)

0.8013
+0.00 (0.00%)
NASDAQ · Last Trade: Jun 9th, 9:45 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close0.8013
Open-
Bid0.7800
Ask0.8000
Day's RangeN/A - N/A
52 Week Range0.5700 - 4.250
Volume2,205
Market Cap2.62M
PE Ratio (TTM)-0.2990
EPS (TTM)-2.7
Dividend & YieldN/A (N/A)
1 Month Average Volume353,929

Chart

About Bone Biologics Corp - Common Stock (BBLG)

Bone Biologics Corp is a biotechnology company focused on developing innovative solutions for the treatment of orthopedic conditions and bone-related injuries. The company is dedicated to advancing the field of bone healing through the creation of biologic products that promote bone regeneration and repair. By leveraging cutting-edge research and technology, they aim to address unmet medical needs in the orthopedic space, enhancing patient outcomes and improving recovery times. Their commitment to scientific advancement positions them at the forefront of bone healing therapies, contributing to the overall improvement of surgical procedures and rehabilitation practices in orthopedics. Read More

News & Press Releases

Bone Biologics Announces 1-for-6 Reverse Stock Split
Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced a planned reverse stock split of its shares of common stock at a ratio of 1-for-6. The reverse stock split will take effect as of 12:01 a.m. ET, on Tuesday, June 10, 2025, and shares of Bone Biologics are expected to trade on a post-split basis on Nasdaq under the existing trading symbol, “BBLG,” at the market open on June 10, 2025.
By Bone Biologics Corporation · Via Business Wire · June 6, 2025
What's going on in today's after hours sessionchartmill.com
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
Via Chartmill · April 3, 2025
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · April 3, 2025
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · October 29, 2024
Bone Biologics Appoints Phillip T. Meikle to its Board of Directors
Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, announces the appointment of Phillip T. Meikle to the Company’s board of directors, effective immediately. Mr. Meikle succeeds Don R. Hankey, who retired from the Board following seven years of service. The number of directors of Bone Biologics remains at four.
By Bone Biologics · Via Business Wire · October 21, 2024
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · October 3, 2024
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · October 3, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · October 2, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · October 2, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · September 25, 2024
Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · September 17, 2024
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In Septemberbenzinga.com
Via Benzinga · September 16, 2024
Bone Biologics Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, announces that Jeffrey Frelick, chief executive officer, will present virtually at the H.C. Wainwright 26th Annual Global Investment Conference being held September 9-11, 2024 in New York City. Bone Biologics’ company presentation will be available here beginning on Monday, September 9th at 7:00 a.m. Eastern time. The presentation will be available on the company’s website for a period of time here.
By Bone Biologics Corporation · Via Business Wire · September 4, 2024
BBLG Stock Earnings: Bone Biologics Beats EPS for Q2 2024investorplace.com
BBLG stock results show that Bone Biologics beat analyst estimates for earnings per share the second quarter of 2024.
Via InvestorPlace · August 12, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Fridayinvestorplace.com
We have all of the biggest pre-market stock movers that traders need to know about on Friday with the latest news breakdowns!
Via InvestorPlace · August 9, 2024
Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds
Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced that it has entered into a definitive agreement for the exercise of certain existing warrants to purchase an aggregate of 781,251 shares of its common stock having an exercise price of $2.43 per share, originally issued in March 2024. The issuance of the shares of common stock issuable upon exercise of the existing warrants is registered pursuant to an effective registration statement on Form S-1 (File No. 333-276771).
By Bone Biologics Corporation · Via Business Wire · August 2, 2024
Nasdaq Surges 1%; Meta Posts Upbeat Earningsbenzinga.com
Via Benzinga · August 1, 2024
Why Carvana Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · August 1, 2024
Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · July 25, 2024
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Sessionbenzinga.com
Via Benzinga · July 24, 2024
Nasdaq Down 2%; Alphabet Posts Upbeat Earningsbenzinga.com
Via Benzinga · July 24, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesdayinvestorplace.com
It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news to start the day with!
Via InvestorPlace · July 24, 2024
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · June 21, 2024
First Two Patients Treated in Pilot Clinical Study with Bone Biologics’ NB1 Bone Graft Device in Spine Fusion
Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, announces that the first two patients have been treated in the multicenter, prospective, randomized pilot clinical study of the Company’s NB1 bone graft device. NB1 is NELL-1 protein combined with demineralized bone matrix (DBM) to provide rapid, specific and guided control over bone regeneration.
By Bone Biologics Corporation · Via Business Wire · June 20, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga.com
Via Benzinga · June 18, 2024